* Helius Medical Technologies Inc reported a quarterly adjusted loss of $3.08 per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $-4.50. The mean expectation of three analysts for the quarter was for a loss of $3.87 per share. Wall Street expected results to range from $-5.04 to $-2.70 per share.
* Revenue rose 21.6% to $135.00 thousand from a year ago; analysts expected $130.50 thousand.
* Helius Medical Technologies Inc's reported EPS for the quarter was a loss of $3.08.
* The company reported a quarterly loss of $2.52 million.
* Helius Medical Technologies Inc shares had fallen by 72.0% this quarter and lost 79.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 14.7% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Helius Medical Technologies Inc is $15.00 This summary was machine generated from LSEG data May 13 at 09:38 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -3.87 -3.08 Beat
Dec. 31 2023 -3.77 -1.47 Beat
Sep. 30 2023 -6.00 -5.49 Beat
Jun. 30 2023 -5.83 -3.00 Beat
Comments